View the historical price chart for SNY to analyze trends and spot opportunities. Use our interactive chart to compare past performance and make informed decisions.
Yes, SNY stock appears to be a good buy in 2025 based on our comprehensive analysis.
Comprehensive analysis of whether SNY stock is a good investment in 2025, including growth drivers, valuation metrics, risk factors, and analyst recommendations.
SNY presents a mixed investment profile for 2025. The company shows strong growth drivers including healthy profit margins of 20.0%, though analyst price targets suggest 33.0% upside potential.
Analyst sentiment is generally positive with 8 buy ratings vs 1 sell ratings.
Investors should weigh the growth potential against the identified risks, particularly high debt-to-equity ratio of 31.71, and consider their own risk tolerance and investment timeline.
Based on our comprehensive analysis of SNY's financial metrics, growth prospects, valuation, analyst sentiment, and risk factors, we recommend a STRONG BUY. This recommendation considers the company's current fundamentals, market position, and future growth potential while accounting for identified risks and market conditions.
Based on revenue growth analysis and market trends, sny stock is projected to reach $38.14 by 2030, representing a -18.4% increase from the current price of $46.75.
Get detailed analyst targets, key factors, and comprehensive forecast analysis
Analyze financial statements and market position
Review price charts and technical indicators
Evaluate market and company-specific risks
Healthcare
Drug Manufacturers - General
Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. The company provides immunolo...
Make buy/hold/sell decision with price targets
Get detailed step-by-step analysis, risk assessment, and investment strategies
46, avenue de la Grande Armée, Paris, 75017
France
Get detailed executive information, governance metrics, and comprehensive corporate data